Dermatology Times has announced a session at EADV 2026 focused on hidradenitis suppurativa (HS) assessment and follow-up care, with programming directed specifically at nurse practitioners (NPs) and physician assistants (PAs) working in dermatology settings.

The announcement identifies the European Academy of Dermatology and Venereology congress in 2026 as the venue for the session. The topic — HS assessment and follow-up — signals continued attention to a chronic inflammatory disease that demands longitudinal management, and it targets the advanced practice provider workforce that increasingly delivers that care in busy clinics.

What does the session cover?

According to the announcement, the session addresses two core components of HS management:

• Assessment of patients with HS, including the evaluation of disease severity and clinical presentation
• Structured follow-up, an area where long-term control of this recurrent disease depends on consistent monitoring and treatment adjustment

The full scope of the curriculum — speaker names, specific assessment instruments, trial data, or case formats — was not detailed in the announcement. Derm Field will update coverage once EADV publishes the complete 2026 scientific program.

Why target NPs and PAs?

Advanced practice providers now handle a substantial share of dermatology visits across the United States and Europe. Sessions built for this audience at a major international congress reflect how congress organizers are broadening programming beyond physician-only tracks. For a disease like HS — where diagnosis is often delayed and follow-up intervals shape outcomes — equipping NPs and PAs with standardized assessment tools carries direct practice implications.

The announcement does not specify whether the session will present new efficacy data, updated guidelines, or competency-based training formats.

What comes next?

The session is scheduled for EADV 2026. Derm Field will follow the published program details, faculty lineup, and any materials released ahead of the congress to report what the training means for HS care delivered by advanced practice clinicians.

Editor's note: This item is based on a brief announcement; the source did not include speaker names, study data, or session specifics beyond the title. Derm Field will not report details that have not been confirmed in published program materials.